Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43M Sell
53,794
-2,471
-4% -$1.64M 0.05% 308
2026
Q1
$30.6M Sell
56,265
-302
-0.5% -$123K 0.04% 362
2025
Q4
$17.7M Buy
56,567
+44,355
+363% +$14.1M 0.02% 486
2025
Q3
$3.3M Buy
12,212
+270
+2% +$61.9K ﹤0.01% 1139
2025
Q2
$2.63M Buy
11,942
+210
+2% +$37.8K ﹤0.01% 1178
2025
Q1
$1.54M Buy
11,732
+1,819
+18% +$254K ﹤0.01% 1384
2024
Q4
$1.36M Sell
9,913
-665
-6% -$91.4K ﹤0.01% 1445
2024
Q3
$1.07M Sell
10,578
-559
-5% -$44.2K ﹤0.01% 1549
2024
Q2
$815K Buy
11,137
+454
+4% +$29.8K ﹤0.01% 1655
2024
Q1
$540K Buy
10,683
+5,409
+103% +$254K ﹤0.01% 1967
2023
Q4
$247K Buy
+5,274
New +$240K ﹤0.01% 2509

Other funds holding AGX

Mariner's AGX Position: Q2 2026 in Review

Mariner reduced its Argan (AGX) stake by 4.4% in Q2 2026, selling an estimated $1.64M and leaving 53,794 shares worth $43M. The position accounts for 0.05% of the portfolio, ranked #308.

Mariner first reported a position in AGX in Q4 2023 and has held it in 11 quarters since. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Mariner held 53,794 shares of Argan worth $43M as of Q2 2026.
  • Mariner sold 2,471 Argan shares in Q2 2026, an estimated $1.64M.
  • Argan made up 0.05% of Mariner's portfolio in Q2 2026, its #308 holding.
  • Mariner first reported a position in Argan in Q4 2023 and has held it in 11 quarters since.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.